Infliximab safety profile and long-term applicability in inflammatory bowel disease: clinical experiences from the eastern side of Europe.
T
T
Molnár
K
K
Farkas
F
F
Nagy
Z
Z
Szepes
T
T
Wittmann
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002648:Child; D005061:Europe, Eastern; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000401:mortality; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016896:Treatment Outcome; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab